Prevention of venous thromboembolism;PREVENTION DE LA MALADIE VEINEUSE THROMBO-EMBOLIQUE

Revue du Praticien

Volumn 46, Issue 10, 1996, Pages 1245-1253

  Samama, Meyer Michel ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; DALTEPARIN; DEXTRAN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN;

DRUG EFFICACY; HUMAN; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; RISK FACTOR; SHORT SURVEY; THROMBOEMBOLISM; ABDOMEN; AGED; HIP PROSTHESIS; REVIEW;

ABDOMEN; AGED; HEPARIN, LOW-MOLECULAR-WEIGHT; HIP PROSTHESIS; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; THROMBOEMBOLISM;

EID: 0029936221     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (43)

1. Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of deep vein thrombosis. Lancet 1969 ; 2 : 230-2.
2. Kakkar VV. The current status of low dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World J Surg 1978 ; 2 : 13-9.
3. Kakkar VV. Prevention of venous thromboembolism. In. Bloom AL, Thomas DP (eds). Tuddenham. ECG, Hæmostasis and Thrombosis. Edinburgh : Churchill Livingstone 1994 : 1361-71.
4. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988 ; 318 : 1162-73.
5. Nurmohamed MT, Rosendaal FR, Büller HR et al. Low-molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992 ; 340 : 152-6
6. Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP. Low molecular weight heparin in the prevention of perioperative thrombosis. BMJ 1992 ; 305 : 913-20.
7. Conférence nationale de consensus: Prophylaxie des thromboses veineuses et des embolies pulmonaires postopératoires (chirurgie générale, gynécologie et orthopédique) : Paris 8 mars. Concours Med 1991 ; 113 : 1333-7.
8. Clagett GP, Anderson FA, Levine MN, Salzman EW, Wheeler HB. Prevention of venous thromboembolism. Chest 1992 ; 102 (suppl) : S 391-S 407. Update in 1995 Chest 108-4 (suppl).
9. Clagett GP, Anderson FA, Levine MN, Salzman EW, Wheeler HB. Prevention of venous thromboembolism. Chest 1992 ; 102 (suppl) : S 391-S 407. Update in 1995 Chest 108-4 (suppl).
10. Nicolaides AN. Prevention of thromboembolism : European consensus statement. In : Bergqvist D, Comerota AJ, Nicolaides AN, Scurr JH (eds). Prevention of venous thromboembolism. London, Los Angeles, Nicosia : Med-Orion Publishing Company. 1994 ; 445-56. Update in 1995 (submitted).
11. Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus group. BMJ 1992 ; 305 : 567-74.
12. Chapuis Y, Augereau B, Clergue F et al. Coordinateurs Ravaud P, Fourcarde A, Durieux P. Prophylaxie et thromboses veineuses post-opératoires : Recommandations de l'AP-HP. Sang Thrombose Vaisseaux 1995 ; 2, 7 : 119-26.
13. Kher A, Gerotziafas GT, Samama MM. Les héparines de bois poids moléculaire (HBPM) dans la prévention des thromboses veineuses des membres en milieu médical In : Priollet P, Samama MM (eds). Progrès en Cardiologie 2. Thromboses veineuses des membres. Paris : Doin ; 1994 ; 8 : 226-34.
14. Pinaquy C, Janvier G. Prophylaxie de la maladie thromboembolique par la contention élastique. Ann Fr Anesth Reanim 1991 ; 11 : 300-2.
15. Jeffrey PC, Nicolaides AM. Graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg 1990 ; 77 : 380-3.
16. Fordyce MJ, Ling RS. A venous foot pump reduces thrombosis after total hip replacement. J Bone Joint Surg 1992 ; 74 (8) : 45-9.
17. Bradley JG, Krugener GH, Jager HJ. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. J Arthroplasty 1993 ; 8 : 57-61.
18. Encke A, Breddin K, The European Fraxiparin Study Group. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J. Surg 1988 ; 73 : 1058-63.
19. European Consensus Statement. Prevention of venous thromboembolism. Intern Angiol 1992 ; 11,3 : 131-9.
20. Barre J, Barsotti J, Planes A et al. Prophylaxie des accidents thromboemboliques veineux en chirurgie orthopédique et traumatique. EMC, Appareil locomoteur 1995 ; 1-14 (Editions Techniques).
21. Bergqvist D. Dextran. In : Goldhaber SZ (ed). Prevention of venous thromboembolism. New York, Basel, Hong Kong : M. Dekker, Inc 1993 ; 167-215.
22. Bergqvist D, Kettlunen K, Fredin H et al. Thromboprophylaxis in hip fracture patients. A prospective randomized comparative study between Org 10172 and dextran. Surgery 1991 ; 109 : 617.
23. Clagett GP, Anderson FA, Hert J, Levine M, Wheeler HW. Prevention of venous thromboembolism. Chest 1995 ; 108, 4 (suppl) : S225-S522
24. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants, mechanism of action, clinical effectiveness and optimal therapeutic ranges. Chest 1995 ; 108, 4 (suppl) : S231-S246.
25. Kakkar VV, Cohen AT, Edmoson RA et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993 ; 341 : 259-65.
26. Levine MN, Hirsh J, Gent M et al. Prevention of deep vein thrombosis after elective hip surgery : a randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991 ; 14 : 545-50.
27. Koller M, Schoch U, Buchmann P, Largiader F, von Felten R, Frick PG. Thrombosis prophylaxis in visceral surgery with the low molecular weight heparin fragment Kabi 2465 (7500 and 2500 anti-Xa IU/day). Haemostasis 1986 ; 16 : 69-70.
28. Samama M, Bernard P, Bonnardot JP, Combe-Tamzali S, Lanson Y, Tissot E. Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis. Br J Surg 1988 ; 75 : 128-31.
29. Bergqvist D, Burmark US, Frisell J et al. Low molecular weight heparin once daily compared with conventional low dose heparin twice daily : a prospective double-blind multicentre trial on prevention of post-operative thrombosis. Br J Surg 1986 ; 73 : 204-8.
30. Bergqvist D, Matzsch T, Burmark US, Frisell J, Guilbaud O, Halbook T. Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thromboembolism. Br J Surg 1988 ; 75 : 888-91.
31. Bergqvist D, Burmark US, Frisell J et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis 2500 versus 5000 Xa I units in 2070 patients. Br J Surg 1995 ; 82 : 496-501.
32. Samama MM. La prophylaxie des accidents thromboemboliques postopératoires. Ann Cardiol Angeiol 1994 ; 43 (3) : 171-6.
33. Warkentin TE, Levine MN, Hirsh J et al. Heparin-induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. N Engl J Med 1995 ; 332 : 1330-5.
34. Hirsch DR, Goldhaber SZ. Medical patients. In : Goldhaber SZ (ed). Prevention of venous thrombo-embolism. New York, Basel, Hong Kong : Marcel Dekker, Inc. 1993 : 485-95.
35. Samama MM. Prophylaxie de la maladie thrombo-embolique veineuse. In : Elias A, Fiessinger JN (eds). Maladie thrombo-embolique veineuse. Paris : Masson, 1995 : 160-70
36. Gallus AS. Prevention in medical patients. In : Hull R, Pineo GF (eds). Prevention of venous thromboembolism. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo : WB Saunders Company, 1995 ; 220-8.
37. Kher A, Gerotziafas GT, Samama MM. Les héparines de bas poids moléculaire dans la prévention des thromboses veineuses des membres en milieu médical. In : Priollet P, Samama MM (eds). Progrès en cardiologie 2. Thromboses veineuses des membres. Paris : Doin, 1994 : 225-33.
38. Kher A, Samama M, Haïat R. L'héparine dans le traitement et la prévention secondaire de l'infarctus du myocarde. Revue critique des principaux essais. Arch Mal Cœur 1991 ; 84 : 1581-6.
39. Turpie AGG, Robinson JG, Doyle DJ et al. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med 1989 ; 320 : 352-7.
40. Sandercock PAG, van den Belt AGM, Lindley RI, Slattery J. Antithrombotic therapy in acute ischaemic stoke : an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry 1993 ; 56 : 17-25.
41. Turpie AGG, Levine MN. A double-blind randomized trial of ORG 10172, LMW heparinoid in the prevention of deep vein thrombosis in patients with thrombotic stroke. Lancet 1987 ; 523-6.
42. Yelnik A, Dizien O, Bussel B et al. Systematic lower limb phlebography in acute spinal cord injury in 147 patients. Paraplegia 1991 ; 29 : 253-60.
43. Green D, Chen D, Chmiel JS et al. Prevention of thromboembolism in spinal cord injury : role of low molecular weight heparin. Arch Phys Med Rehabil 1994 ; 75 : 290-2.